• Kura Oncology Chief Commercial Officer Brian T. Powl sold 10,000 common shares on May 21, 2026 at USD 11 per share.
• Holdings stood at 173,614 shares following the sale.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kura Oncology Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-236838), on May 22, 2026, and is solely responsible for the information contained therein.